Christopher Kuebler

Insider profile

Currently holds a position at Waters Corp

Performance

Overall performance
3.5

Performance over holding periods
3.5
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 73% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Independent Director Waters Corp May 1, 2006 -
Independent Director Nektar Therapeutics Dec. 1, 2001 - Dec. 31, 2018

Christopher Kuebler's trades of Waters Corp's stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
113.47
Quantity 16,078 -4.5%
Value US$1,468,260
Transaction date
Proposed sale
Price
290.57
Quantity 7,381
Value US$898,328
Transaction date
Sale
Price
427.99
Quantity 91,276 +22.2%
Value US$3,807,631
Transaction date
Proposed sale
Price
361.64
Quantity 4,000
Value US$1,446,560
Transaction date
Sale
Price
291.48
Quantity 4,000 -21.8%
Value US$1,165,920
Transaction date
Proposed sale
Price
291.48
Quantity 4,000
Value US$1,165,920
Transaction date
Sale
Price
328.78
Quantity 4,000 -22.1%
Value US$1,315,120
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-08-07 2026-08-06 S Sale
16,078 -4.5%
113.47
US$1,468,260
16,078 -4.5% 113.47 US$1,468,260
2026-08-06 2026-08-06 PrS Proposed sale
7,381
290.57
US$898,328
7,381 290.57 US$898,328
2024-05-16 2024-05-15 S Sale
91,276 +22.2%
427.99
US$3,807,631
91,276 +22.2% 427.99 US$3,807,631
2024-05-15 2024-05-15 PrS Proposed sale
4,000
361.64
US$1,446,560
4,000 361.64 US$1,446,560
2023-08-07 2023-08-04 S Sale
4,000 -21.8%
291.48
US$1,165,920
4,000 -21.8% 291.48 US$1,165,920
2023-08-04 2023-08-04 PrS Proposed sale
4,000
291.48
US$1,165,920
4,000 291.48 US$1,165,920
2022-05-23 2022-05-19 S Sale
4,000 -22.1%
328.78
US$1,315,120
4,000 -22.1% 328.78 US$1,315,120